Surgery Partners (SGRY) Payables (2014 - 2026)

Surgery Partners has disclosed Payables across 13 years of filings, most recently posting $168.6 million for Q1 2026.

• Payables for Q1 2026 came in at $168.6 million, up 2.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $168.6 million (up 2.18% YoY), and the FY2025 annual result was $208.7 million, changed 0.0% from the prior year.
• Payables came in at $168.6 million for Q1 2026 at Surgery Partners, down from $208.7 million in the prior quarter.
• In the past five years, Payables ranged from a high of $208.7 million in Q4 2024 to a low of $122.9 million in Q1 2022.
• The 5-year median for Payables is $168.6 million (2026), against an average of $162.1 million.
• Across the five-year window, Payables soared 32.32% in 2024 and retreated 5.23% in 2025, its largest moves.
• Surgery Partners' Payables stood at $151.6 million in 2022, then grew by 13.32% to $171.8 million in 2023, then grew by 21.48% to $208.7 million in 2024, then changed by 0.0% to $208.7 million in 2025, then fell by 19.21% to $168.6 million in 2026.
• The last three Payables figures came in at $168.6 million (Q1 2026), $208.7 million (Q4 2025), and $174.6 million (Q3 2025), per Business Quant data.